The role of the estrogen in neuroprotection: Implications for neurodegenerative diseases

Neuroendocrinology Letters

Volumn 24, Issue 3-4, 2003, Pages 141-147

  Cho, John J ^a   Iannucci, Francesco A ^a   Fraile, Melissa ^a   Franco, Joseph ^a   Alesius, Tracy N ^a   Stefano, George B ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

17 estradiol; Alzheimer's disease; Estrogen cell surface receptors; Estrogen receptors; Free radicals; Microglia; Nitric oxide; Parkinson's disease; Schizophrenia

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; NEUROTROPHIN; NITRIC OXIDE;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL SURVIVAL; DEGENERATIVE DISEASE; DISEASE COURSE; GENOMICS; HUMAN; MEDICAL RESEARCH; NERVE CELL LESION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

EID: 0041785440     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. McEwen B. Genome and Hormones: Gender Differences in Physiology Invited Review: Estrogen effects on the brain: multiple sites and molecular mechanisms. Journal of Applied Physiology 2001: 91:2785-2801.
2. Carreau S, Bourguiba S, Lambard S, Galeraud-Denis I, Genissel C, Levallet J. Reproductive system: aromatase and estrogens. Mol Cell Endocrinol 2002; 193:137.
3. Cummings JL, Vinters HV, Cole GM, Khachaturian ZS. Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 1998: S2-17.
4. Cho JJ, Cadet P, Salamon E, Mantione K, Stefano GB. The nongenomic protective effects of estrogen on the male cardiovascular system: clinical and therapeutic implications in aging men. Med Sci Monit 2003: RA63-8.
5. Goodman Y, Bruce AJ, Cheng B, Mattson MP. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66:1836-1844.
6. Behl C, Widmann M, Trapp T, Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995; 216:473-482.
7. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997; 51:535-541.
8. Dluzen D. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res 1997; 767:340-344.
9. Gridley KE, Green PS, Simpkins J W. A novel, synergistic interaction between 17 beta estradiol and gutathione in the protection of neurons against β-amyloid 25-35-incuced toxicity in vitro. Mol Pharmacol 1998; 54:874-80.
10. Mooradian AD. Antioxidant properties of steroids. J Steroid Biochem Mol Biol 1993; 45:509-511.
11. Levin ER. Cell localization, physiology, and nongenomic actions of estrogen receptors. J
12. Collins, P, Webb C. Estrogen hits the surface. Nat Med 1999; 5:1130-31.
13. Kuiper GG, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138:863-70.
14. McEwen B, Parsons B. Gonadal steroid action on the brain: neurochemistry and neuropharmacology. Annu Rev Pharmacol Toxicol 1982; 22:555-598.
15. DonCarlos LL, Greene GL, Morrell JI. Distribution of estrogen receptor-immunoreactive cells in the forebrain of the female guinea pig. J Comp Neurol 1991; 305:591-612.
16. Küppers E, Beyer C. Expression of estrogen receptor alpha and beat mRNA in the developing and adult mouse stratium. Neurosci Letters 1999; 276:95-98.
17. Wang L et al. Estrogen receptor (ER)beta knockout mice reveal a role for ERbeta in migration of cortical neurons in the developing brain. Proc Natl Acad Sci 2003; 100(2):703-8.
18. Cowley SM, Hoare S, Mosselman S, Parker MG. Estrogen receptor alpha and beta form heterodimers on DNA. J Biol Chem 1997; 272:19858-18862.
19. Petersen DN, Tkalcevic GT, Koza-Taylor P, Turi. TG, Brown TA. Identification of estrogen receptor beta2, a functional variant of estrogen receptor beta expressed in normal rat tissues. Endocrinology 1998; 139:1082-1092.
20. Hanstein B, Lilu H, Yaancisin MC, Brown M. Functional analysis of a novel estrogen receptor-beta isoforms. Mol. Endocirnol. 1999; 13:129-137.
21. Resnick EM, Schreihofer DA, Shupnik MA. Truncated estrogen receptor TERP-1 modulates transcriptional activity by direct interactions with estrogen receptors α and β. J Biol Chem 2000; 275:7158-7166.
22. Beato M, Klug J. Steroid hormone receptors: an update. Hum Reprod Update 2000; 6:225-236.
23. Pratt WB, Toft DO. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997; 18: 306-360.
24. Sand P, Luckhaus C, Schlurmann K, Gotz M, Deckert J. Untangling the human estrogen receptor gene structure. J Neural Transm 2002;109(5-6):567-83.
25. Miller MM, Hyder SM, Assayag R, Panarella SR, Tousignant P, Franklin KB. Estrogen modulates spontaneous alternation and the cholinergic phenotype in the basal forebrain. Neuroscience 1999; 91:1143-1153.
26. Lee K, Richardson CD, Razik MA, Kwatra MM, Schwinn DA. Multiple potential regulatory elements in the 5′ flanking region of the human alpha 1a-adrenergic receptor. DNA Seq 1998; 8:271-276.
27. Zhu YS, Pfaff DW. DNA binding of hypothalamic nuclear proteins on estrogen response element and preproenkephalin promoter: modification by estrogen. Neuroendocrinology 1995; 62:454-466.
28. Stone DJ, Song Y, Anderson CP, Krohn KK, Finch CE, Rozovsky I. Bidirectional transcription regulation of glial fibrillary acidic protein by estradiol in vivo and in vitro. Endocrinology 1998; 139:3202-3209.
29. Teixeira C, Reed JC, Pratt MA. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res 1995; 55:3902-3907.
30. Chen DF, Schneider GE, Martinou JC, Tonegawa S. Bcl-2 promotes regeneration of severed axons in mammalian CNS. Nature 1997; 385:434-439.
31. Holm K, Isacson O. Factors intrinsic to the neuron can induce and maintain its ability to promote axonal outgrowth: a role for BCL2? Trends Neurosci 1999; 22:269-273.
32. Bogdanov MB, Ferrante RJ, Mueller G, Ramos LE, Martinou JC, Beal MF. Oxidative stress is attenuated in mice overexpressing BCL-2. Neurosci Lett 1999; 262:33-36.
33. Pike CJ. Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease. J Neurochem 1999; 72:1552-1563.
34. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999; 19:2455-2463.
35. Tremblay A, Tremblay GB, Labrie F, Giguere V. Ligand-independent recruitment of SRC-1 to' estrogen receptor beta through phosphorylation of activation function AF-1. Mol Cell 1999; 3: 513-519.
36. Sawada H, Ibi M, Kihara T, Urushitani M, Akaike A, Shimohama S. Estradiol protects mesencephalic dopaminergic neurons from oxidative stress-induced neuronal death. J Neurosci Res 1998; 54:707-719.
37. Singh M, Meyer EM, Simpkins JW. The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female sprague dawley rats. Endocrinology 1995; 136:2320-2324.
38. Toran-Allerand CD, Miranda RC, Bentham WD, Sohrabji F, Brown TJ, Hochberg RB, MacLusky NJ. Estrogen receptors colocalize with low-affinity nerve growth factor receptors in cholinergic neurons of the basal forebrain. Proc Natl Acad Sci USA 1992; 89:4668-4672.
39. Toran-Allerand CO. Mechanisms of estrogen action during neuronal development: mediation by interactions with the neurotrophins and their receptors? J Steroid Biochem Mol Biol 1996; 56:169-178.
40. Behl C, Holsboer F. The female sex hormone oestrogen as a neuroprotectant. Trends Pharmacol Sci 1999; 20:441-444.
41. Mermelstein PG, Becker JB, Surmeier DJ. Estradiol reduces calcium currents in rat neostriatal neurons via a membrane receptor. J Neurosci Res 1996; 16:595-604.
42. Duenas M, Luquin S, Chowen JA, Torres-Aleman I, Naftolin F, Garcia-Segura LM. Gonadal hormone regulation of insulin growth factor-I-Like immunoreactivity in hypotalamic astroglia of developing and adult rat. Neuroendocriology 1994; 59:528-538.
43. Duenas M, Torres-Aleman I, Naftolin F, Garcia-Segura LM. Interaction of insulin- like growth factor-I and estradiol signaling pathways on hypotalamic neuronal differentiation. Neuroscience 1996; 74:531-539.
44. Azcotia I, Sierra A, and Garcia-Segura LM. Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signaling. J Neurosci Res 1999; 58: 815-822.
45. Stefano G B, Prevot V, Beauvillain J C, Fimiani C, Welters I, Cadet P, Breon C, Pestel J, Salzet M, Bilfinger T V. Estradiol coupling to human monocyte nitric oxide release is dependent on intracellular calcium transients: Evidence for an estrogen surface receptor. J Immunol 1999; (163):3758-3763.
46. Stefano G B, Prevot V, Beuvillain J C, Bilfinger T V, Fimiani C, Welters I, Fricchione G L. Acute exposure to estrogen to human endothelia results in nitric oxide release mediated by an estrogen surface receptor coupled to intracellular calcium transients. Circulation 2000d; (101):1594-1597.
47. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW. Estrogen receptor alpha mediates the nongenomic activation of endothetial nitric oxide synthase by estrogen. J Clin Invest 1999; 103:401-6.
48. Razandi M, Pedram A, Greene GL, Levin ER. Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 1999; 13:307-19.
49. Razandi M, Oh P, Pedram A, Schnitzer J, Levin ER. ERs associate with and regulate the production of caveolin: implications for signaling and cellular actions. Mol Endocrinol 2002; 16:100-15.
50. Kelly MJ, Levin ER. Rapid action of plasma membrane estrogen receptors. Trens Endocrinol Metabolism 2001; 12:152-156.
51. Kelly MJ, Wagner EJ. Estrogen modulation of G-protein-coupled receptor. TEM 1999; 10:369-374.
52. Stefano G B, Goumaon Y, Bilfinger T V, Welters I, Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia expressa muopiate receptor. Progress in Neurobiology 2000b; (60):531-544.
53. Stefano G B, Peter D. Cell surface estrogen receptors coupled to cNOS mediate immune and vascular tissue regulation. Theraputic implications. Medical Science Monitor 2001; (7):1066-1074.
54. Dhandapani KM, Brann DW. Estrogen-astrocyte interactions: implications for neuroprotection. BMC Neurosci. 2002; 3(1):6.
55. Ganter S, Northoff H, Mannel D, Gebicke-Harter PJ. Growth control of cultured microglia. J Neurosci Res 1992; 33:218-230.
56. Drew PD, Chavis JA. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol 2000; 111:77-85.
57. Burns A. Protection against Alzheimer's disease. Lancet 1996; 9025:420-421.
58. Wickelgren I. Estrogen: A new weapon against Alzheimer's. Science 1997; 276:676-677.
59. Tang Ming Xin. Effect of estrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348:9025. 429-432.
60. Friedrich, M.J. "Teasing Out Effects of Estrogen on the Brain." JAMA 2002; 287:29-30.
61. Waters, Rob. Estrogen to prevent Alzheimer's. Health 1997; 11: 40-42.
62. de ta Torre J C, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder. The role of constituitive nitric oxide. Brain Res Rev 2000; 34:119-136.
63. Stefano G B, Goumaon Y, Bilfinger T V, Welters I, Cadet P. Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Progress in Neurobiology 2000b; (60):531-544.
64. Benz D, Cadet P, Mantione K, Zhu W, Stefano AG B, Tonal nitric oxide and health: A free radical and a scavenger of free radicals. Medical Science Monitor 2002; (8):1-4.
65. Hafner H. Gender differences in schizophrenia. Psychoneuro-endocrinology 2003; 2:17-54.
66. Rao ML, Kolsch H. Effects of estrogen on brain development and neuroprotection--implications for negative symptoms in schizophrenia. Psychoneuroendocrinology 2003; 2:83-96.
67. Bergemann N, Parzer P, Nagl I, Salbach B, Runnebaum B, Mundt Ch, Resch F. Acute psychiatric admission and menstrual cycle phase in women with schizophrenia. Arch Women Ment Health 2002; 5(3):119-26.
68. Stefano G B, Bilfinger T V Fricchione G L. The immune neuro-link and the macrophage: Postcardiotomy delirium, HIV-associated dementia and psychiatry. Prog Neurobiol 1994; (42):475-488.
69. Stefano GB, Zhu W, Mantione K, Jones D, Salamon E, Cho J and Cadet P. 17-β estradiol down regulates ganglionic microglial cells via nitric oxide release: Presence of a fragment for estrogen receptor β. Neuroendocrinol Lett 2003. In press.
70. Nilsen J, Brinton RD. Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology 2002; 143:205-12.
71. Wise PM, Dubal DB, Wilson ME, Rau SW, Bottner M, Rosewell KL. Estradiol is a protective factor in the adult and aging brain: understanding of mechanisms derived from in vivo and in vitro studies. Brain Res Brain Res Rev 2001; 37(1-3):313-9.
72. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM. Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998; 18:1253-8.
73. Wise PM. Estradiol: a protective factor in the adult brain. J Pediatr Endocrinol Metab 2000; 136:1425-9.
74. Stefano GB, Neenan K, Cadet P, Magazine H I, Bilfinger T V. Ischemic preconditioning - an opiate constituitive nitric oxide molecular hypothesis. Med Sci Moni 2001a; (7):1357-1375.
75. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P. The nuclear receptor superfamily: the second decade. Cell 1995; 83: 835-839.
76. Stefano GB, Goumon Y, Casares F, Cadet P, Fricchione G L, Rialas C, Peter D, Sonetti D, Guarna M, Welters I, Bianchi E. Endogenous morphine. Trends in Neurosciencees 2000c; (9) 436-442.
77. Stefano G B, Magazine H I. Nitric oxide autoregulation and its significance. Modern Aspects of Immunobiology 2001; (1): 182-186.
78. Esch T, Stefano G B. Proinflammation: A common denominator or initiatior of different pathophysiological disease processes. Medical Science Monitor 2002; (8):1-9.
79. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289:2663-72.